179894-45-2

Basic information

• Product Name: Quinoline, 6-(2,3-dichlorophenyl)-1,2-dihydro-2,2,4-trimethyl-
• CAS NO: 179894-45-2
• Molecular Formula: C18H17Cl2N
• Molecular Weight: 318.246
• Mol File: 179894-45-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Quinoline, 6-(2,3-dichlorophenyl)-1,2-dihydro-2,2,4-trimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Quinoline, 6-(2,3-dichlorophenyl)-1,2-dihydro-2,2,4-trimethyl-(179894-45-2)
• EPA Substance Registry System: Quinoline, 6-(2,3-dichlorophenyl)-1,2-dihydro-2,2,4-trimethyl-(179894-45-2)

Safety Data

• Hazardous Substances Data: 179894-45-2(Hazardous Substances Data)

Upstream product

• 56961-77-4 1-bromo-2,3-dichlorobenzene 
• 179894-36-1 (1-tert-butyloxycarbonyl-1,2-dihydro-2,2,4-trimethyl-6-quinolinyl)boronic acid 

Relevant articles and documents

STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

Steroid receptor modulator compounds and methods

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.

Tricyclic steroid receptor modulator compounds and methods

Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.